Investor Ideas #Potcasts
531, #Cannabis News and #Stocks on the Move; (CSE: $IPOT.C) (TSX: $HEXO.TO)
(NYSE: $HEXO) (TSXV: $NDVA.V)
(TSX: $FAF.TO)
Delta, Kelowna, BC, February 16, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2021/021621-StocksToWatch.mp3
Read this in full
at https://www.investorideas.com/news/2021/cannabis-potcasts/02161IPOT-HEXO-NDVA-FAF.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we will be looking at a few public and private company
announcements.
Isracann
Biosciences Inc. (CSE:
IPOT) (OTC:
ISCNF), an Israel-based company focused on becoming a
premier low cost, high quality cannabis producer announced that
its flagship Hefer Valley-based Ein Hahoresh Farm is in full readiness to
commence growing and production activities.
With the phase one 54,000 sq. ft. of
greenhouse canopy fully constructed and extensive processing capability
in-place, Isracann is moving rapidly towards the commencement of
industrial-scale operations aimed at servicing both domestic and European
export markets in 2021.
The Ein Hahoresh farm operations and
construction teams recently expanded the onsite post-harvest facility in
preparation to meet increased demand from regional partners representing both
domestic and export market sales opportunities. Subject to final Security and
Ministry of Health approvals for the requisite farm operating license, the
Company is preparing the property for imminent production activities.
Currently, Isracann and its local
consultants have scheduled the commencement of planting for early March to
coincide with the start of optimal climatic conditions, subject to the timely
receipt of final government approvals.
Isracann COO Matt Chatterton
comments, “We are pleased to report that we have concluded every step as
outlined by our regional consultants who have brought proven and invaluable
experience in working with the Israeli government. Additionally, it should be
noted that the various representatives of the ministries involved have been
professional, open, and forthright in their dealings with us at all times.
Everyone has been working within the context of the global pandemic and we are
grateful to all concerned to have achieved so much during what have been
extremely trying times. We look forward to reporting on the conclusion of the
upcoming inspections and confidently anticipate an exciting period of activity
ahead as we continue to build, grow and create value in Israel.”
HEXO
Corp. (TSX:
HEXO) (NYSE:
HEXO) and Zenabis
Global Inc. (TSX:
ZENA) announced that
they have entered into a definitive arrangement agreement (the
"Arrangement Agreement") under which HEXO will acquire, by way of
court-approved plan of arrangement under the Business Corporations Act (British Columbia), all of Zenabis’
issued and outstanding common shares in an all-share transaction valued at
approximately $235 million. Under the terms of the Arrangement Agreement,
Zenabis shareholders will receive 0.01772 of a HEXO common share in exchange
for each Zenabis common share held (the “Exchange Ratio”). The Exchange Ratio
implies a premium per Zenabis common share of approximately 19% based on the
20-day volume-weighted average price ("VWAP") of Zenabis common
shares on TSX and HEXO common shares on TSX as of February 12, 2021. Warrants
and incentive securities of Zenabis will be adjusted in accordance with their
terms to ultimately become exercisable to receive common shares of HEXO based
on the share exchange ratio.
The Transaction was unanimously
approved by the board of directors of each of HEXO and Zenabis (in the case of
Zenabis’ board of directors, after receiving the unanimous recommendation of a
special committee formed for purposes of the Transaction), and Zenabis’ board
of directors unanimously recommends that its shareholders vote in favour of the
Transaction.
Transaction
Highlights
●
Strengthened
domestic brands: Based on HEXO’s and Zenabis’ most recent
interim quarterly financial statements and results, and those of the other top
licensed producers in Canada, the combined organization would be a top three
licensed producer in terms of combined Canadian recreational cannabis sales.
●
Foothold
in Europe: The Transaction gives HEXO immediate access to the
European medical cannabis market through Zenabis’ local partner, with an
established facility in the European Union supplying pharmaceutical products to
the European market. The facility also serves as a European Union Good
Manufacturing Practice packaging and distribution centre for medical cannabis
products produced in Zenabis' Atholville Facility.
●
Accretive
synergies:
HEXO estimates that the combined entity may realize annual synergies of
approximately $20 million within one year of close, through cost of goods
reductions, additional capacity utilization in HEXO’s Belleville Centre of
Excellence and selling, general and administrative savings, which, if realized,
should allow HEXO to continue its path towards positive earnings.
●
Capacity
boost with state-of-the-art cultivation infrastructure: The
proposed Transaction would give HEXO access to licensed capacity to produce
approximately 111,200 kg of additional high-quality cannabis annually. The
Transaction would result in HEXO acquiring two indoor facilities (approximately
635,000 sq. ft.) and access to a 2.1 million sq. ft. greenhouse facility,
totalling approximately 2.735 million sq. ft. of near-term cultivation space
offering diversified growing and production techniques. This provides a
platform for growth and foundation from which to strengthen and diversify our
portfolio of brands.
“We're thrilled to welcome the
Zenabis team into the HEXO family. Zenabis has built solid relationships and
they share HEXO’s vision of bringing exceptional branded cannabis experiences
to adults everywhere, in Canada and abroad” said Sebastien St-Louis, CEO and
co-founder of HEXO Corp. “We are proceeding with this transaction because we
believe it should be accretive for our shareholders, and it also positions HEXO
for accelerated domestic and international growth while supporting near-term
requirements for additional licensed capacity. HEXO’s growth strategy includes
expanding our global presence, and this acquisition is an important step in
that direction.”
“This is a compelling combination.
Our brands and strains strength across Canada, coupled with our international
footprint and state of the art low cost and high quality cultivation facilities
complements HEXO’s business, creating an industry leader. Like HEXO, Zenabis
believes that the combination should deliver meaningful synergies, a stronger
financial position with increased flexibility, and should position the combined
company to meet growing consumer demand on a national and international basis.
I believe this transaction is beneficial to our shareholders, customers,
partners, and employees. We look forward to working closely with HEXO to
complete this transaction," added Shai Altman, CEO of Zenabis.
Sundial
Growers Inc. (NASDAQ:
SNDL), a Canadian licensed producer of recreational
cannabis and Indiva Limited (TSXV:
NDVA) (OTCQX:
NDVAF), a leading Canadian producer of cannabis edibles, announced a
$22,000,000 strategic investment into Indiva by Sundial.
The Investment will be completed in
the form of a brokered private placement led by ATB Capital Markets Inc. of
25,000,000 common shares of Indiva at a price of $0.44 per Common Share, to
raise gross proceeds of $11,000,000, and a non-revolving term loan facility to
Indiva in the principal amount of $11,000,000. It is anticipated that Sundial
will be the sole subscriber in the Placement. Proceeds to Indiva, net of fees,
commissions and expenses are expected to be approximately $20.9 million.
"Sundial is pleased to support
the development of Indiva's high-quality products," said Zach George,
Chief Executive Officer of Sundial. "This transaction broadens our
exposure to the rapidly expanding cannabis edibles category."
Indiva intends to use the net
proceeds of the Placement and Term Loan to retire its outstanding debt in full,
which includes its demand loan and promissory note, as well as for working
capital and other general corporate purposes.
"We are delighted to welcome Sundial
as a strategic investor in Indiva," said Niel Marotta, President and Chief
Executive Officer of Indiva. "The capital from this $22 million investment
significantly improves Indiva's balance sheet, expands our working capital, and
provides the resources necessary to support strong growth in our business. Indiva will now have the ability to make
additional capital investments, primarily into automation, which will drive
higher throughput and profitability, while ensuring our product quality
maintains the best-in-class standard our customers and clients depend
upon. Indiva's bolstered financial
strength will ensure we can defend our market share position as a top edibles
producer in Canada, and continue to bring new and innovative cannabis products
to of-age Canadians."
Sundial and Indiva intend to
complete the Investment on or about February 23, 2021, subject to certain
conditions customary for transactions of this nature, including, but not
limited to, the receipt of all necessary approvals, including the approval of
the TSX Venture Exchange.
The securities issued under the
Placement will be subject to a statutory hold period of four months and one day
following the closing of the Placement.
Indiva has agreed to: (a) pay to ATB
a cash commission equal to 3.0% of the aggregate gross proceeds received by
Indiva from the Placement from Sundial and 6.0% of the aggregate gross proceeds
received by Indiva from the Placement from subscribers other than Sundial, if
applicable; and (b) pay to the Agent a cash commission equal to 2.0% of the
total loan commitment under the Term Loan.
Fire
& Flower Holdings Corp. (TSX:
FAF)
(OTCQX:
FFLWF), a leading cannabis retailer with a proprietary
e-commerce and digital retail platform,
today announced that it has submitted an initial
application to list its common shares on the Nasdaq Stock Market.
The anticipated Nasdaq listing is
part of Fire & Flower's growth strategy which is focused on expanding its
brand to markets outside of Canada. The Company anticipates that the Nasdaq
listing will assist in attracting retail and institutional investors interested
in Fire & Flower's international growth ambitions as well as provide the
Company with increased access to strategic partners, deal-flow and value
creation opportunities.
Trevor Fencott, Chief Executive
Officer of Fire & Flower, commented, "We are firmly committed to
building Fire & Flower into one of the leading cannabis retailers in the
world. Our ability to deliver a superior
cannabis product and customer experience, along with our cutting-edge
technology, has driven our success in Canada and strongly positions our Company
for continued expansion in new high-growth markets."
Fencott continued, "Our focus
on building a leadership position within the cannabis industry goes hand in
hand with driving increased value for our shareholders. This application to list on Nasdaq is a major
step forward in expanding our shareholder base in the United States. We will continue to pursue domestic and international
opportunities for accelerated growth in the years ahead and look forward to
updating our broadening shareholder base as we move ahead."
Fire & Flower will continue to
be listed on the Toronto Stock Exchange under the symbol "FAF". The
listing of the Company's common shares on Nasdaq remains subject to the review
and approval of the Company's listing application and the satisfaction of all
applicable listing and regulatory requirements. The Company has retained
Dentons as legal counsel in connection with the application to list on Nasdaq.
Investor ideas reminds all
listeners to read our disclaimers and disclosures on the Investorideas.com
website and that this podcast is not an endorsement to buy products or services
or securities. Investors are reminded all investment involves risk and possible
loss of investment.
Investors can trade these stocks and other ideas on our site using our list of top stock trading apps
including Robinhood , Acorn, Stash and
others.
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Hear the investor ideas potcast on Spotify
To hear more
Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases or
sale of stocks, services or products. Nothing on our sites should be construed
as an offer or solicitation to buy or sell products or securities. All
investing involves risk and possible losses. This site is currently compensated
for news publication and distribution, social media and marketing, content
creation and more. Disclosure is posted for each compensated news release,
content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to
regulations of each country. Please read Investorideas.com privacy
policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile App for
iPhone and Android
Join
our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800
665 0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
